Skip to main content
SpringerLink
Log in

Insulin Aspart

A Viewpoint by Lutz Heinemann

  • Adis New Drug Profile
  • Guest Commentary
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Home P, Lindholm A, Hylleberg B. Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. Diabetes Care 1998; 21(11): 1904–9

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. PROFIL Institute for Metabolic Research GmbH, Neuss, Germany

    Lutz Heinemann

Authors
  1. Lutz Heinemann
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heinemann, L. Insulin Aspart. Drugs 57, 766 (1999). https://doi.org/10.2165/00003495-199957050-00014

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199957050-00014

Search

Navigation